Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $24.61 Consensus PT from Analysts
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a […]
More Stories
Iran Declares Strait of Hormuz Open, but Warns of Risk From Mines
By Chris Summers Iran said on April 9 that the Strait of Hormuz is open to all civilian shipping but...
Remote-Job Postings Rise 20 Percent Sequentially in 1st Quarter: Report
By Mary Prenon Although many American companies, both large and small, have called employees back to the office over the...
Updates on XO, Kitty Season 4 Renewal: Release Date, Cast, and Spoiler
Netflix’s popular romantic comedy drama, XO, Kitty is back with all new connections and a story. The American television drama...
US State Department Issues Travel Advisory for 3 African Nations
By Naveen Athrappully The U.S. Department of State recently issued travel advisories for Nigeria, Ethiopia, and São Tomé and Príncipe,...
US Forces Will Remain in Region Until Iran Complies With Agreement: Trump
By Victoria Friedman U.S. President Donald Trump said on April 8 that warships and personnel will remain in the region...
Homeward Bound: Artemis II Leaves Lunar Space, Reveals ‘Earthset’ Photos
By T.J. Muscaro HOUSTON—The Artemis II astronauts are on their way home from the moon. NASA’s Reid Wiseman, Victor Glover,...